HOME >> BIOLOGY >> NEWS
Toxicogenomics provides insight on assigning breast cancer drugs

DENVER, CO -- Toxicology is getting a facelift with an infusion of genomics and proteomics--and powerful computing--that will help researchers predict adverse effects to chemicals in the environment, as well as the effectiveness of drugs used to treat breast cancer patients.

Knowing how a person's body would allow a toxic effect to occur at the gene and protein level, may someday make it easier for doctors to decide what treatment is more appropriate. Such information also would lead to the development of better biomarkers to detect toxicity earlier during medical treatment, researchers said today at the 2003 American Association for the Advancement of Science (AAAS) Annual Meeting.

Like a wad of gum stuck in a child's hair, a small breast cancer cell from a tissue mass requires delicate unraveling and extraction. Traditionally, researchers have studied the genetics of the whole tumor mass because of the difficulty faced when trying to excise the cell of interest. Now, Emanuel Petricoin of the Food and Drug Administration has been working with a special video-game like microscope that pulls selected cells out, like a tractor beam. When combined with new protein array technologies he and his colleague Lance Liotta (National Cancer Institute) have also been developing, the new microscope technology has allowed him to study toxicity and the cancer-associated "miswiring" of the cellular circuitry in breast cancer patients receiving different kinds of drugs or combination of drugs.

After the cell is isolated from the tumor mass, it is ready to have its proteome (the protein complement encoded by a person's genome) analyzed. To do this, Petricoin has also developed protein array tests to detect subtle changes in protein phosphorylation along many key "nodes" within the cellular circuitry. Phosphorylation occurs when a phosphate group is removed from ATP, a component in many cellular circuits. While it is possible to know of the existence of a ge
'"/>


14-Feb-2003


Page: 1 2 3

Related biology news :

1. Study by Israeli scientists provides insight on DNA code
2. Study by Tufts biologist provides window into progression of some degenerative diseases
3. Rolling Store provides model for overcoming barriers to healthy foods and better health outcomes
4. Common worm provides insights into salmonella virulence
5. Avastin-Tarceva combo provides one-two punch against lung cancer
6. Motion that powers sperm provides key to unravelling rare genetic disorder
7. Chemical reaction in birds provides sense of direction during migratory flights
8. Engineered virus provides impetus in search for HIV vaccine
9. Pollution history documented through shell remains provides tool to study ecosystem change
10. Microbes trick provides a template for willowy crystals
11. Migraine mouse provides insight into neurobiology of devastating headaches

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2019)... , ... April 04, 2019 , ... ... with integrated linear encoders providing 0.05 microns and 0.005 microns resolution, respectively. The ... and drive variations are available, from fast DC-servo motors with linear encoders and ...
(Date:4/4/2019)... ... April 02, 2019 , ... The live session ... into the connectivity between product risk management (ISO 14971) and the clinical risk ... process. , With increasing global regulation and reimbursement challenges faced by medical device ...
(Date:4/1/2019)... (PRWEB) , ... April 01, 2019 , ... ... and System for Characterizing Skin Related Conditions” by the US Patent and Trademark ... The patent is an invention by uBiome collaborators Dr. Zachary Apte, Dr. ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... Sonny Bar Lisa, or Sonny ... for approximately two months. After a series of diagnostics, an MRI was performed ... owner, Alison, researched the injury and found that VetStem Regenerative Cell Therapy ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global ... $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). ... Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to begin ...
(Date:4/4/2019)... (PRWEB) , ... April 03, 2019 , ... ... together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference ... offers insights into the industry’s challenges and opportunities with high-level panels and discussions ...
(Date:3/27/2019)... ... March 27, 2019 , ... In honor of National Nutrition Month, ... importance of healthy meals and good nutrition. This month, Chef Jodi Abel appeared ... chef. , The first segment addressed the nutritional value of USDA’s MyPlate, ...
Breaking Biology Technology:
Cached News: